Compare Diageo plc (DEO) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diageo plc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Diageo plc trades at $86.92 (market cap $47.67B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.52 (market cap $25.27B). The key difference: Diageo plc is the larger of the two by market cap, and Diageo plc pays the higher dividend (2.3%). Which is the better fit depends on your goals — on Pluang, investors hold Diageo plc for 66 Days and Royalty Pharma plc Class A Ordinary Shares for 0 Days on average.
| DEO | RPRX | |
|---|---|---|
Market Cap | $47.67B | $25.27B |
Volume | 893,372 | 3,671,183 |
Sector | Consumer Staples | Health |
52-Week High | $102.14 | $63.96 |
52-Week Low | $72.47 | $35.44 |
Typical Hold Time | 66 Days | 0 Days |
Enterprise Value | $68.09B | $32.50B |
Dividend Yield | 2.3% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Diageo (DEO) trades at $84.73, down 0.06% on the day, with a bearish technical signal from moving averages. The company maintains strong profitability with a 59.47% gross margin and has beaten EPS estimates in the last three quarters. Recent news highlights marketing initiatives and a CFO transition planned for 2027. The balance sheet shows $2.65B in cash against $23.75B in total debt, with a debt-to-asset ratio improving to 48.05% in 2026.
The outlook is mixed: analyst consensus leans bullish (49% buy ratings) with a focus on the US turnaround plan, but 2026 projections show declining revenue and net income. Key risks include execution of the restructuring, competitive pressures, and regulatory challenges in markets like India. The stock offers income via dividends but faces near-term fundamental headwinds.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diageo plc
Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Smirnoff, and Guinness. It operates a vast portfolio of spirits and beers across more than 180 countries.
Read more on DEO →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
